GYNOL II EXTRA STRENGTH OTC
Generic Name and Formulations:
Nonoxynol-9 3% (150mg/applicatorful); contraceptive jelly; contains parabens.
Personal Products Co.
Indications for GYNOL II EXTRA STRENGTH:
1 teaspoonful spread over the surface and rim of diaphragm prior to intercourse provides 6 hrs protection. Reapply prior to each intercourse (if used with diaphragm do not remove diaphragm; use applicator). Do not remove before 6 hrs following intercourse. Extr Str may be used with condom or alone: 1 applicatorful into vagina up to 1 hr before intercourse and before each additional intercourse. For all: use with each intercourse regardless of day of menstrual cycle.
Discontinue if irritation occurs.
Local vaginal or penile irritation.
Gynol—2.5oz, 3.8oz (w. applicator)
Gynol Ext Str—2.85g (w. applicator)
Ortho-Gynol—3.8oz (w. applicator)
Endocrinology Advisor Articles
- Higher BUN May Increase Risk for Incident Diabetes
- Efficacy of Novel GLP-1 Receptor Agonist Drug Device Examined
- Takeout Food May Increase Adverse Health Consequences in Children
- Nonhormonal Options Available for Menopause Symptom Relief
- Plasma Volume Changes Mediate Risk of CV Mortality With Empagliflozin
- New Consensus Recommendations on Use of Continuous Glucose Monitoring
- Does Genetic Susceptibility Lead to Late-Onset Type 1 Diabetes?
- Clinical Outcomes in T2D: Low-Carbohydrate vs Calorie-Restricted Diet
- New Continuous Glucose Monitoring System Now Available for Medicare Patients
- Text Message-Delivered Interventions Effective for Weight Management
- Effect of Intra-Articular Depot Betamethasone on Insulin Resistance in T2D
- Gastric Bypass vs Sleeve Gastrectomy Outcomes in Morbid Obesity
- Acute Kidney Injury Increases Risk for Postdischarge Hypoglycemia in Diabetes
- Novel Deep Learning System May Help Identify Diabetic Retinopathy
- Trends in CVD, Risk Factors, and Medications in Children With T1D